L26/O-013 Extended letrozole protocol versus letrozole-inositol combination for ovulation induction in letrozole-resistant polycystic ovary syndrome women
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.013 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Soliman und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Study question How much more effective is the extended letrozole protocol (ELP) versus the letrozole-inositol combination (ILC) for ovulation induction in letrozole-resistant PCOS women? Summary answer In letrozole-resistant PCOS women, the combination of letrozole with inositol is more effective than extended letrozole protocol for ovulation induction and improving clinical pregnancy rates. What is known already Letrozole is a first-line treatment for ovulation induction in women with polycystic ovary syndrome (PCOS). However, a subset of women exhibits resistance to conventional letrozole protocols. Study design, size, duration A total of 200 letrozole-resistant PCOS women were randomly allocated into two equal groups (n = 100 each). Participants/materials, setting, methods A total of 200 letrozole-resistant PCOS women were randomly allocated into two equal groups (n = 100 each): the ELP group, receiving 5 mg letrozole daily for 7 days, and the ILC group, receiving 2 grams of inositol twice daily for three months, with 5 mg letrozole daily for 5 days administered during the final treatment cycle. Main results and the role of chance The ovulation rate was significantly higher in the ILC group (64%) compared to the ELP group (47%) (p = 0.016). Similarly, the clinical pregnancy rate was significantly higher in the ILC group (56%) compared to the ELP group (37%) (p = 0.007). The post-treatment Ferriman-Gallwey score was significantly reduced in the ILC group (16.4±2.2) compared to the ELP group (18.7±2.6) (p = 0.001). There was no significant difference in endometrial thickness or the incidence of OHSS between the two groups. Limitations, reasons for caution A potential limitation is the lack of long-term follow-up data on ongoing pregnancies and live birth rates. Wider implications of the findings For patients who fail to ovulate with the standard 5-day letrozole protocol, the combination of letrozole with inositols presents a more effective treatment option compared to simply extending the duration of letrozole administration. Trial registration number No
Zitieren
APA
Soliman, A., Tawfik, W., & Osman, A. (2026). L26/O-013 Extended letrozole protocol versus letrozole-inositol combination for ovulation induction in letrozole-resistant polycystic ovary syndrome women. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.013
Vancouver
Soliman A, Tawfik W, Osman A. L26/O-013 Extended letrozole protocol versus letrozole-inositol combination for ovulation induction in letrozole-resistant polycystic ovary syndrome women. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.013
BibTeX
@article{Soliman2026,
author = {Soliman, A. and Tawfik, W. and Osman, A.},
title = {L26/O-013 Extended letrozole protocol versus letrozole-inositol combination for ovulation induction in letrozole-resistant polycystic ovary syndrome women},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.013}
}
EUVIMED